Sofosbuvir Velpatasvir

Name: Sofosbuvir Velpatasvir
Brand: Maheshwari Medical Agency
Price: 6900 INR
Availability: InStock

Price 6900 INR/ Box

Get a Price/Quote

MOQ : 2 Boxes

Sofosbuvir Velpatasvir Specification

Indication
Treatment of chronic hepatitis C virus (HCV) infection

Dosage Form
Tablet

Salt Composition
Sofosbuvir 400 mg + Velpatasvir 100 mg

Enzyme Types
Nucleotide analogue polymerase inhibitor and NS5A inhibitor

Feature
Combination oral therapy for HCV, once daily dosing, high efficacy

Ingredients
Sofosbuvir and Velpatasvir

Application
Antiviral therapy

Physical Color/Texture
Film-coated tablet, typically light brown

Fermentation Smell
Odorless

Storage Instructions
Store at room temperature below 30C, protect from moisture

Shelf Life
24 months

Patient Suitability
Adults

Administration Route
Oral

Pack Size
28 tablets per bottle

Drug Class
Direct-acting antiviral

Brand Name
Available under various brand names (e.g., Epclusa)

ATC Code
J05AP55

Packaging Type
HDPE bottle

Prescription Status
Prescription only

Sofosbuvir Velpatasvir Trade Information

Minimum Order Quantity
2 Boxes

Supply Ability
100 Boxes Per Day

Delivery Time
1 Week

Main Domestic Market
All India

About Sofosbuvir Velpatasvir

Sofosbuvir Velpatasvir, available in a reduced price and customizable 28-tablet HDPE bottle, is a monumental advancement for adults battling chronic hepatitis C infection. Procure this champion antiviral combination, offered under various prestigious brand names like Epclusa, for once-daily oral administration. Each film-coated, odorless tablet blends excellent efficacy with a robust safety profile. Distributed by leading suppliers and traders in India, this prescription-only direct-acting antiviral achieves exceptional results, setting a new standard in HCV treatment and longevity with a 24-month shelf life.

Specific and Versatile Utility of Sofosbuvir Velpatasvir

Sofosbuvir Velpatasvir is specifically used for treating chronic hepatitis C in adults, acting as a potent antiviral therapy. The combination leverages nucleotide analogue polymerase and NS5A inhibition, ensuring broad efficacy across HCV genotypes. Used as a once-daily oral formulation, it features high effectiveness, safety, and convenience. Users benefit from a streamlined regimen and robust protection, making it an excellent option in clinical settings-and monumentally impactful for patients and healthcare providers alike.

FOB Port, Domestic and Export Market Details

Sofosbuvir Velpatasvir is available for prompt handover at major Indian FOB ports, with a competitive rate structure for bulk procurement. The product's list price is determined based on quantity and market trends, ensuring affordability for suppliers and distributors. It serves the main domestic market across India and is actively exported to international markets, meeting global standards. Clients benefit from efficient distribution channels and reliable supply, championing excellence in market reach and service.

Specification

Country of Origin	Made in India
Strength	400 + 100MG
Form	Tablet
Manufacturer	DR REDDY
Brand	DR. REDDY
Packaging Size	28 TAB
Prescription/Non prescription	Prescription
Treatment	sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infecti
Composition	SOFOSBUVIR AND VELPATASVIR

FAQ's of Sofosbuvir Velpatasvir:

Q: How is Sofosbuvir Velpatasvir administered for hepatitis C?

A: Sofosbuvir Velpatasvir is administered orally, typically as one film-coated tablet taken once daily by adults, as prescribed by a healthcare professional.

Q: What makes Sofosbuvir Velpatasvir an excellent choice for chronic hepatitis C therapy?

A: This medication is a combination of two antiviral agents, offering high efficacy across multiple HCV genotypes, convenient once-daily dosing, and a strong safety profile.

Q: Where can I procure Sofosbuvir Velpatasvir at a reduced price?

A: Sofosbuvir Velpatasvir can be procured through authorized distributors, suppliers, and traders in India, often at a reduced price for bulk or institutional buyers.

Q: When should patients consider starting treatment with Sofosbuvir Velpatasvir?

A: Treatment should begin after a confirmed diagnosis of chronic hepatitis C and on the recommendation of a healthcare provider. Prescription is required.

Q: What is the process for storage and handling of Sofosbuvir Velpatasvir tablets?

A: Store the tablets in the original HDPE bottle, at room temperature below 30C, and protect them from moisture to maintain efficacy throughout their 24-month shelf life.

Q: What benefit does the combination of Sofosbuvir and Velpatasvir offer over single-agent therapy?

A: This combination targets two essential enzymes in the HCV replication process, increasing the likelihood of viral clearance and reducing the chance of resistance compared to single-agent therapy.

Tell us about your requirement